IP Update: California Institute of Technology; Roche NimbleGen; Corning; and More | GenomeWeb

The California Institute of Technology of Pasadena has received US Patent No. 8,129,176, "Integrated active flux microfluidic devices and methods." The claimed device is capable of detecting the presence of molecules, such as polynucleotides, proteins, or antigen/antibody complexes, that are correlated to a hybridization signal from an optically detectable reporter associated with the bound molecules. Hybridization probes are immobilized on a substrate exposed to channels of the device that form a closed loop, for circulation of sample to contact complementary probes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.